Fundamentals
Perhaps you have experienced those moments when your thoughts feel less sharp, or when recalling a name or a fact seems to require more effort than it once did. This sensation, a subtle shift in cognitive fluidity, can be unsettling.
It prompts a deeper inquiry into the intricate workings of our biological systems, particularly the delicate balance of hormones that orchestrate so much of our well-being. Your personal experience with these changes is a valid starting point for understanding the profound connection between your endocrine system and your mental clarity.
Our bodies operate through a sophisticated network of chemical messengers, and among the most influential are androgens. These steroid hormones, primarily testosterone and dihydrotestosterone (DHT), are often associated with male characteristics, yet their influence extends far beyond, playing a critical role in the functioning of the brain for all individuals. Androgens contribute to neuroprotection, mood regulation, and various aspects of cognitive performance, including memory and processing speed. Their presence helps maintain the structural integrity and optimal function of neural pathways.
When we consider interventions that modulate these essential hormones, such as anti-androgen medications, it becomes clear that widespread effects are possible. Anti-androgens are a class of therapeutic agents designed to counteract the actions of androgens in the body. They achieve this by blocking androgen receptors, preventing androgen synthesis, or accelerating androgen breakdown. Clinically, these compounds serve various purposes, from managing prostate cancer and certain dermatological conditions like acne and hair loss, to facilitating gender-affirming care.
Altering fundamental hormonal systems can lead to widespread effects, including impacts on brain function.
The introduction of anti-androgens into the body intentionally alters a fundamental hormonal system. This modulation, while serving a specific therapeutic aim, can have ripple effects across interconnected biological networks. The brain, being highly sensitive to hormonal fluctuations, is particularly susceptible to these changes. Understanding the potential long-term cognitive effects of anti-androgen use requires acknowledging this systemic interconnectedness.
What Are Androgens and Their Brain Role?
Androgens are a group of steroid hormones that include testosterone and its more potent metabolite, dihydrotestosterone. While commonly recognized for their influence on reproductive health and secondary sexual characteristics, these hormones are also crucial for central nervous system function. They exert their effects by binding to androgen receptors located throughout the brain, including regions vital for cognitive processes such as the hippocampus and the prefrontal cortex.
The presence of androgens supports neuronal health, influences neurotransmitter systems, and contributes to synaptic plasticity, which is the brain’s ability to adapt and reorganize its connections. A robust androgenic environment is associated with better verbal memory, spatial abilities, and executive functions. Therefore, any intervention that significantly reduces androgenic signaling holds the potential to influence these cognitive domains.
How Anti-Androgens Modulate Hormonal Balance
Anti-androgens operate through distinct mechanisms to reduce androgenic influence. Some agents, like spironolactone or bicalutamide, act as androgen receptor antagonists, directly blocking the receptors where androgens would normally bind. This prevents the hormones from exerting their effects on target cells. Other anti-androgens, such as finasteride and dutasteride, are 5-alpha reductase inhibitors. They prevent the conversion of testosterone into the more potent DHT, thereby reducing the overall androgenic signal.
A different class of agents, such as GnRH agonists or antagonists (e.g. leuprolide, degarelix), suppress androgen production at its source by acting on the hypothalamic-pituitary-gonadal (HPG) axis. This central regulatory system controls hormone production from the gonads. By disrupting this axis, these medications significantly lower systemic androgen levels. Each mechanism, while effective in its primary application, introduces a unique set of downstream effects on the body’s hormonal landscape, with potential implications for cognitive function.
Intermediate
Understanding the long-term cognitive effects of anti-androgen use requires a closer look at the specific clinical protocols and the biological pathways they influence. These therapies, while essential for managing certain conditions, recalibrate the body’s hormonal communication system, leading to downstream effects that can impact mental acuity and emotional well-being.
Mechanisms of Anti-Androgen Action and Cognitive Impact
Anti-androgens exert their influence through several distinct biochemical pathways, each with unique implications for cognitive function.
- Androgen Receptor Blockade ∞ Medications such as spironolactone and bicalutamide directly compete with androgens for binding sites on androgen receptors. When these receptors, present in various brain regions, are occupied by an antagonist, the natural androgenic signals cannot be received. This interruption can affect neural processes dependent on androgen receptor activation, potentially influencing cognitive domains like memory and attention.
- Enzyme Inhibition ∞ Compounds like finasteride and dutasteride, known as 5-alpha reductase inhibitors, prevent the conversion of testosterone to dihydrotestosterone (DHT). DHT is a potent androgen with significant neurobiological roles. Reducing its levels can alter neurosteroidogenesis, the local production of steroids within the brain, which is crucial for maintaining synaptic plasticity and neuronal health. Studies indicate that while the dementia risk associated with these agents may not persist long-term, the risk of depression remains a concern.
- Gonadotropin-Releasing Hormone (GnRH) Modulation ∞ GnRH agonists (e.g. leuprolide) and antagonists (e.g. degarelix) suppress the production of androgens by acting on the pituitary gland, a central component of the HPG axis. This leads to a profound reduction in systemic testosterone. Such comprehensive androgen deprivation, often seen in prostate cancer treatment, has been linked to impairments in specific cognitive domains, including verbal memory, visuospatial abilities, and executive function.
Anti-androgen therapies, by altering androgen signaling, can influence brain function through various molecular pathways.
Cognitive Domains Affected by Androgen Modulation
The brain is a complex organ, and hormonal shifts can manifest in varied cognitive changes. Research on individuals undergoing androgen deprivation therapy (ADT) for prostate cancer, for example, has highlighted several cognitive domains that may experience alterations.
These include ∞
- Memory Function ∞ Both verbal and spatial memory can be affected. Patients sometimes report difficulty recalling words, names, or navigating familiar environments. This aligns with the known distribution of androgen receptors in the hippocampus, a brain region central to memory formation and retrieval.
- Executive Functions ∞ This broad category encompasses higher-order cognitive processes such as attention, planning, problem-solving, and decision-making. Individuals may experience reduced mental flexibility or slower processing speed, impacting their ability to manage complex tasks.
- Visuospatial Abilities ∞ Challenges with visual perception and spatial reasoning, such as interpreting maps or understanding three-dimensional relationships, have been reported in some studies.
- Mood Regulation ∞ Beyond direct cognitive effects, androgen deprivation can significantly influence mood, with increased risks of depression and anxiety observed in various populations using anti-androgens. These mood changes can, in turn, indirectly affect cognitive performance.
Clinical Protocols and Hormonal Recalibration
The impact on cognitive function is often proportional to the degree and duration of androgen suppression. Different clinical protocols for anti-androgen use naturally lead to varying hormonal milieus.
For instance, in Testosterone Replacement Therapy (TRT) for men, the goal is to optimize androgen levels. Standard protocols often involve weekly intramuscular injections of Testosterone Cypionate, sometimes combined with Gonadorelin to maintain natural testosterone production and fertility, and Anastrozole to manage estrogen conversion. This approach aims to restore physiological androgen levels, which can support cognitive health and mitigate symptoms of low testosterone, such as reduced mental clarity and mood disturbances.
Similarly, Testosterone Replacement Therapy for women, particularly in peri-menopausal and post-menopausal stages, uses lower doses of Testosterone Cypionate, often alongside Progesterone or via pellet therapy. This targeted hormonal optimization seeks to address symptoms like irregular cycles, mood changes, and low libido, while also supporting cognitive vitality. Estrogen, a metabolite of testosterone, also plays a crucial role in female brain health, influencing synaptic plasticity and neuroprotection.
When considering anti-androgen use, especially in contexts like prostate cancer treatment, the objective is often profound androgen suppression. This creates a different hormonal landscape compared to optimization protocols.
| Anti-Androgen Class | Primary Mechanism of Action | Common Clinical Applications |
|---|---|---|
| Androgen Receptor Antagonists | Directly block androgen receptors, preventing testosterone and DHT from binding. | Prostate cancer, gender-affirming care, hirsutism, acne. |
| 5-Alpha Reductase Inhibitors | Inhibit the enzyme that converts testosterone to DHT, reducing DHT levels. | Benign prostatic hyperplasia, androgenic alopecia. |
| GnRH Agonists/Antagonists | Suppress pituitary gonadotropin release, leading to reduced testicular androgen production. | Prostate cancer, endometriosis, precocious puberty, gender-affirming care. |
| CYP17 Inhibitors | Block an enzyme involved in androgen synthesis in the adrenal glands and testes. | Castration-resistant prostate cancer. |
The interplay between androgens and estrogens in the brain is also significant. While anti-androgens reduce androgenic signaling, the resulting hormonal environment, which may involve altered estrogen levels or ratios, also impacts cognitive function. Estrogen has neuroprotective properties and influences synaptic plasticity, making its balance a key consideration in overall brain health.
Different anti-androgen protocols create distinct hormonal environments, influencing cognitive outcomes.
Considering Estrogen’s Role in Cognition
It is important to recognize that the cognitive effects of anti-androgen use are not solely attributable to androgen deficiency. Estrogen, a hormone often considered primarily female, plays a significant role in brain function for all individuals. In men, a portion of testosterone is converted to estrogen via the aromatase enzyme, and this estrogen contributes to bone health, cardiovascular function, and cognitive processes.
When anti-androgens reduce testosterone, they can indirectly reduce estrogen levels in men, or alter the androgen-to-estrogen ratio. In women, anti-androgen use can also impact the delicate balance of sex steroids. Estrogen receptors are widely distributed in brain regions associated with learning and memory, and estrogen itself has been shown to promote neurogenesis, synaptic plasticity, and protect against oxidative stress.
Therefore, the cognitive profile observed with anti-androgen use reflects a complex interplay of reduced androgenic signaling and the resulting shifts in the broader hormonal milieu, including estrogenic influence.
Academic
The long-term cognitive effects of anti-androgen use extend beyond simple hormonal depletion, reaching into the intricate neurobiological architecture of the brain. A deep understanding requires examining the precise molecular and cellular mechanisms by which androgen deprivation influences neural function, integrating insights from endocrinology, neurobiology, and systems biology.
Neuroendocrine Axes and Cognitive Architecture
At the core of hormonal regulation lies the Hypothalamic-Pituitary-Gonadal (HPG) axis, a sophisticated feedback system that orchestrates sex steroid production. The hypothalamus releases gonadotropin-releasing hormone (GnRH), which stimulates the pituitary to secrete luteinizing hormone (LH) and follicle-stimulating hormone (FSH). These gonadotropins, in turn, act on the gonads to produce testosterone in men and estrogens and progesterone in women. Anti-androgens disrupt this axis at various points, leading to a cascade of neurobiological consequences.
For instance, GnRH agonists and antagonists directly suppress pituitary function, leading to profound systemic androgen deprivation. Other anti-androgens interfere with androgen action at the receptor level or inhibit their synthesis. This systemic disruption has direct implications for the brain, where androgen receptors are widely expressed. The brain itself is a steroidogenic organ, capable of synthesizing neurosteroids locally from cholesterol or circulating precursors. Systemic androgen deprivation can impair this local neurosteroidogenesis, further compromising neural function.
Molecular Mechanisms of Androgen Action in the Brain
Androgens influence brain function through both genomic and non-genomic mechanisms.
- Genomic Effects ∞ Androgen receptors (ARs) are ligand-activated transcription factors. Upon binding testosterone or DHT, activated ARs translocate to the nucleus, where they bind to specific DNA sequences (androgen response elements) to regulate gene expression. This gene regulation impacts neuronal survival, differentiation, and the synthesis of proteins essential for synaptic plasticity and neurotransmission. Regions rich in ARs, such as the hippocampus and prefrontal cortex, are critical for memory and executive functions, explaining why their disruption can lead to cognitive changes.
- Non-Genomic Effects ∞ Androgens also exert rapid, non-genomic effects by interacting with membrane-bound receptors or intracellular signaling pathways. These rapid actions can modulate ion channels, activate kinase cascades, and influence neurotransmitter release, contributing to immediate changes in neuronal excitability and synaptic strength.
Androgen deprivation can alter the balance of key neurotransmitter systems, including GABA, glutamate, dopamine, and serotonin. For example, testosterone has been shown to influence GABAergic and glutamatergic signaling, which are fundamental for learning and memory. Reduced androgenic input can lead to imbalances in these systems, contributing to cognitive deficits and mood disturbances.
Inflammation, Oxidative Stress, and Neurodegeneration
Beyond direct receptor-mediated effects, chronic androgen deficiency, often induced by anti-androgen therapy, can contribute to neuroinflammation and oxidative stress within the brain. Androgens, particularly testosterone, possess neuroprotective properties, including antioxidant and anti-inflammatory actions. When androgen levels decline, the brain may become more vulnerable to inflammatory processes and oxidative damage, which are recognized contributors to neurodegenerative conditions and cognitive decline.
Studies suggest that androgen deprivation can lead to a reduction in white matter integrity and impact hypothalamic functions, further exacerbating cognitive issues. The long-term consequences of this neuroinflammatory state can include impaired neurogenesis (the formation of new neurons), reduced synaptic plasticity, and ultimately, neuronal dysfunction or loss.
Androgen deprivation can induce neuroinflammation and oxidative stress, contributing to cognitive decline.
Clinical Evidence and Research Considerations
Clinical research on the cognitive effects of anti-androgen use, particularly androgen deprivation therapy (ADT) for prostate cancer, presents a complex picture. While some studies consistently report impairments in specific cognitive domains like verbal memory, executive function, and visuospatial abilities, others show mixed or inconclusive results.
This variability can be attributed to several factors ∞
- Heterogeneity of Patient Populations ∞ Differences in age, baseline cognitive status, comorbidities, and duration of ADT can influence outcomes.
- Methodological Challenges ∞ Variations in neurocognitive assessment tools, lack of consistent pre-treatment baseline data, and the presence of confounding factors (e.g. cancer-related fatigue, depression, other medications) make direct comparisons challenging.
- Type of Anti-Androgen ∞ Different anti-androgens have distinct mechanisms and varying degrees of brain penetration, potentially leading to different cognitive profiles. For example, some newer androgen receptor signaling inhibitors may have more pronounced central nervous system effects due to higher brain tissue levels.
Despite these complexities, a growing body of evidence suggests that prolonged androgen deprivation can be associated with measurable declines in cognitive performance and psychosocial well-being, particularly in older men. Some large population-based studies have indicated an increased risk of dementia, including Alzheimer’s disease, with ADT, though results remain somewhat contradictory across all analyses.
| Cognitive Domain | Observed Changes | Underlying Neurobiological Mechanisms |
|---|---|---|
| Memory (Verbal, Spatial) | Difficulty with recall, learning new information. | Reduced hippocampal neurogenesis, altered synaptic plasticity, changes in androgen receptor signaling in memory circuits. |
| Executive Function | Slower processing speed, impaired planning, reduced mental flexibility. | Impact on prefrontal cortex function, altered neurotransmitter balance (e.g. dopamine, serotonin), reduced white matter integrity. |
| Visuospatial Abilities | Challenges with visual perception, spatial reasoning. | Potential changes in parietal lobe function, altered neural connectivity. |
| Mood Regulation | Increased risk of depression, anxiety. | Neurotransmitter dysregulation, neuroinflammation, impact on limbic system circuits. |
Personalized Wellness Protocols for Cognitive Support
For individuals experiencing cognitive shifts related to hormonal changes, personalized wellness protocols offer a path toward recalibrating biological systems and supporting brain health. These strategies aim to optimize the endocrine environment and enhance neuroprotective mechanisms.
Testosterone Replacement Therapy (TRT), when clinically indicated for men with low testosterone, can significantly improve cognitive function. Protocols often involve precise dosing of Testosterone Cypionate via weekly intramuscular injections. Adjunctive therapies like Gonadorelin can help preserve endogenous testicular function and fertility, while Anastrozole may be used to manage estrogen conversion, ensuring a balanced hormonal profile. Restoring physiological testosterone levels can enhance neuroprotection, support synaptic plasticity, and improve memory and executive function.
For women, hormonal optimization protocols are tailored to address the unique hormonal landscape of pre-menopausal, peri-menopausal, and post-menopausal stages. Low-dose Testosterone Cypionate, typically administered weekly via subcutaneous injection, can improve libido, mood, and cognitive vitality. Progesterone, prescribed based on menopausal status, plays a crucial role in brain health, influencing GABAergic signaling and neuroprotection.
Pellet therapy offers a long-acting option for testosterone delivery, with Anastrozole considered when estrogen management is appropriate. These interventions aim to restore a hormonal balance that supports overall well-being, including cognitive resilience.
Beyond traditional hormone replacement, advanced peptide therapies offer additional avenues for cognitive support. Growth Hormone Peptide Therapy, utilizing agents like Sermorelin, Ipamorelin / CJC-1295, Tesamorelin, Hexarelin, and MK-677, can stimulate the body’s natural growth hormone release. Growth hormone and its downstream mediator, IGF-1, are known to promote neurogenesis, enhance synaptic plasticity, and exert neuroprotective effects, potentially improving memory, mental processing speed, and overall cognitive function.
Other targeted peptides, such as Pentadeca Arginate (PDA), are gaining recognition for their potential in tissue repair, healing, and inflammation modulation. PDA has shown promise in reducing oxidative stress in the brain and enhancing GABA neurotransmission, which can contribute to improved mood and cognitive stability. These peptides represent a sophisticated approach to supporting the body’s innate healing and regenerative capacities, extending to the delicate neural environment.
How Do Hormonal Shifts Influence Brain Plasticity?
The brain is a remarkably adaptable organ, constantly reorganizing its neural connections in response to experiences and environmental cues. This capacity, known as neuroplasticity, is profoundly influenced by hormonal signals. Androgens and estrogens play critical roles in regulating synaptic density, neuronal survival, and the formation of new neurons (neurogenesis), particularly in regions like the hippocampus, which is central to learning and memory.
When anti-androgens alter the hormonal milieu, they can disrupt these processes. A reduction in androgenic signaling can lead to decreased synaptic plasticity, making it harder for the brain to form new connections or consolidate memories. This can manifest as difficulties in learning, reduced cognitive flexibility, and impaired memory recall.
The intricate feedback loops within the HPG axis mean that changes in one hormone can have widespread effects on the entire neuroendocrine system, impacting the brain’s ability to maintain its adaptive capacity.
Can Targeted Hormonal Interventions Prevent Cognitive Decline?
The question of whether targeted hormonal interventions can prevent or mitigate cognitive decline associated with anti-androgen use is a subject of ongoing research and clinical application. For individuals experiencing hypogonadism, whether due to age or medical interventions, restoring physiological hormone levels through therapies like TRT can offer significant cognitive benefits. By providing the necessary hormonal signals, these protocols aim to support neuroprotective pathways, reduce neuroinflammation, and enhance synaptic function.
The effectiveness of these interventions depends on various factors, including the individual’s baseline health, the specific hormonal imbalance, and the timing and precision of the treatment. A personalized approach, guided by comprehensive lab work and clinical assessment, is essential to tailor protocols that optimize hormonal balance while minimizing potential risks. The goal is to create an internal environment that supports optimal brain health and cognitive resilience, even in the face of previous hormonal challenges.
References
- Asif, Muhammad, et al. “Long-Term Effects of Androgen Deprivation Therapy on Cognitive Function in Prostate Cancer Patients.” Journal of Neonatal Surgery, vol. 14, no. 32s, 2025, pp. 3473-3478.
- Bruce, Julian Lloyd. “Executive Function at Risk ∞ Androgen Deprivation Therapy, Cognitive Decline, and the Question of Fitness to Serve.” Herald Scholarly Open Access, 2025.
- Garcia-Argibay, Miguel, et al. “Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide.” JAMA Network Open, vol. 5, no. 12, 2022, pp. e2247122-e2247122.
- Huang, Jing, et al. “Potential role of ghrelin in neuroprotection and cognitive function ∞ implications for diabetic cognitive impairment.” Frontiers in Endocrinology, vol. 16, 2025.
- Leranth, Csaba, et al. “Role of Androgens and the Androgen Receptor in Remodeling of Spine Synapses in Limbic Brain Areas.” Frontiers in Neuroendocrinology, vol. 25, no. 2-3, 2004, pp. 111-120.
- Micevych, Paul E. and Jennifer M. Dominguez. “Estrogen Actions in the Brain and the Basis for Differential Action in Men and Women ∞ A Case for Sex-Specific Medicines.” Pharmacological Reviews, vol. 61, no. 1, 2009, pp. 1-29.
- Reddy, P. “Neurosteroidogenesis today ∞ Novel targets for neuroactive steroid synthesis and action and their relevance for translational research.” Progress in Neurobiology, vol. 113, 2014, pp. 1-19.
- Rhea, Elizabeth M. et al. “Growth Hormone (GH) and GH-Releasing Peptide-6 Increase Brain Insulin-Like Growth Factor-I Expression and Activate Intracellular Signaling Pathways Involved in Neuroprotection.” Endocrinology, vol. 144, no. 5, 2003, pp. 1836-1842.
- Salminen, E. et al. “Cognitive effects of testosterone and finasteride administration in older hypogonadal men.” Psychoneuroendocrinology, vol. 29, no. 8, 2004, pp. 1019-1029.
- Shukri, Nor Azlina, et al. “Aldosterone in the brain and cognition ∞ knowns and unknowns.” Frontiers in Endocrinology, vol. 15, 2024.
- Sun, Meng-Meng, et al. “Cognitive Impairment in Men with Prostate Cancer Treated with Androgen Deprivation Therapy ∞ A Systematic Review and Meta-Analysis.” Journal of Urology, vol. 200, no. 1, 2018, pp. 111-118.
- Vogel, S. et al. “Mineralocorticoid Receptor Antagonists and Cognitive Outcomes in Cardiovascular Disease and Beyond ∞ A Systematic Review.” International Journal of Molecular Sciences, vol. 26, no. 3, 2025, p. 1976.
- Wang, Y. et al. “An Updated Review ∞ Androgens and Cognitive Impairment in Older Men.” Frontiers in Endocrinology, vol. 11, 2020, p. 593011.
- Yagi, S. et al. “Improvement of cognitive impairment in female type 2 diabetes mellitus mice by spironolactone.” Journal of the Renin-Angiotensin-Aldosterone System, vol. 13, no. 1, 2012, pp. 84-90.
- Zubiaurre-Elorza, Leire, et al. “Endogenous and Exogenous Estrogen Exposures ∞ How Women’s Reproductive Health Can Drive Brain Aging and Inform Alzheimer’s Prevention.” Frontiers in Neuroendocrinology, vol. 64, 2024, p. 1010098.
Reflection
The journey to understanding your own biological systems is a deeply personal one, often beginning with a subtle shift in how you experience your body and mind. The insights shared here, particularly concerning the long-term cognitive effects of anti-androgen use, are not meant to create alarm, but rather to provide clarity and empower you with knowledge. Recognizing the intricate dance of hormones within your neuroendocrine system is the first step toward reclaiming vitality and function without compromise.
Your body possesses an innate intelligence, and when its delicate hormonal balance is disrupted, whether by therapeutic interventions or natural aging processes, it communicates these changes through symptoms that deserve attention. This knowledge is a compass, guiding you to ask more precise questions about your health, to seek comprehensive assessments, and to consider personalized strategies that honor your unique biological blueprint.
What Steps Can You Take Next?
Armed with a deeper understanding of how anti-androgens can influence cognitive well-being, you might now consider proactive steps. This could involve discussing your hormonal health with a clinician who specializes in endocrine optimization. A thorough evaluation of your current hormonal status, including a detailed analysis of sex steroids, gonadotropins, and relevant metabolic markers, can provide a clear picture of your internal landscape.
For those who have undergone or are considering anti-androgen therapy, a discussion about cognitive monitoring and supportive strategies is essential. This might involve exploring the potential for targeted hormonal optimization protocols, such as Testosterone Replacement Therapy or specific peptide therapies, designed to support neuroprotection and cognitive resilience. Remember, the goal is not merely to address symptoms, but to recalibrate your biological systems for sustained well-being.
Embracing a Proactive Health Philosophy
Your health journey is a continuous process of learning and adaptation. The information presented here serves as a foundation, inviting you to become an active participant in your own care. By understanding the profound interconnectedness of your hormonal health, metabolic function, and cognitive vitality, you gain the capacity to make informed decisions that align with your long-term goals for a vibrant and fully functional life.
This proactive philosophy, grounded in scientific understanding and a deep respect for individual experience, is the pathway to sustained well-being.
Glossary
biological systems
endocrine system
processing speed
androgen receptors
prostate cancer
long-term cognitive effects
androgenic signaling
synaptic plasticity
5-alpha reductase inhibitors
androgen receptor
cognitive function
androgen levels
cognitive effects
cognitive domains
neurosteroidogenesis
androgen deprivation
executive function
androgen deprivation therapy
challenges with visual perception
testosterone replacement therapy
testosterone cypionate
testosterone replacement
hormonal optimization
brain health
brain function
oxidative stress
gnrh agonists
influence brain function through
cognitive decline
neuroinflammation
cognitive resilience
hormonal balance
